Status:
RECRUITING
End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
Lead Sponsor:
Rush University Medical Center
Collaborating Sponsors:
St. John Fisher College
University of Minnesota
Conditions:
Disabilities Multiple
Eligibility:
All Genders
3-89 years
Brief Summary
People with disabilities (PWD) experience increased risk of diagnostic error-sometimes due to attributing symptoms to disability rather than a potentially new or co-morbid conditions. As well, some di...
Detailed Description
Aim 1: Identify and create understanding of mechanisms underlying diagnostic overshadowing. A baseline audit of diagnostic processes is being conducted, including data from the Safer DX Checklist and...
Eligibility Criteria
Inclusion
- • Patients aged 3-89 who received billed charges
Exclusion
- Patients under age 3 or over age 89.
- Patients with secondary diagnosis of dementia as the population is already known to be at increased risk of diagnostic error
Key Trial Info
Start Date :
November 22 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2029
Estimated Enrollment :
120000 Patients enrolled
Trial Details
Trial ID
NCT06608758
Start Date
November 22 2024
End Date
July 31 2029
Last Update
June 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612